Myeloid cells are highly diverse, so we analysed myeloid-specific RPLS scores (13 RPLS signature genes with predicted myeloid origin by digital cytometry) in scRNA-seq data generated from immune cells (CD45+) of 3 iCCA patients undergoing tumour resection.28 Under adjuvant capecitabine, one patient exhibited short disease-free survival (9 months; S-DFS) and two others exhibited long disease-free survival (L-DFS; ≥24 months) (figure 3H). The gene discussed is PTPRC; the disease is neoplasm.